Request for Covid-19 Impact Assessment of this Report
The United States Nifedipine market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Nifedipine market, reaching US$ million by the year 2028. As for the Europe Nifedipine landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Nifedipine players cover Bayer, Actavis, Teva, and Pfizer, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Nifedipine market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Nifedipine Controlled Release Tablets
Nifedipine Extended Action Tablets
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Primary Pulmonary Hypertension
Heart Failure
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Bayer
Actavis
Teva
Pfizer
Shyndec
Honglin
Huanghai
Yabao
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Nifedipine Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Nifedipine by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Nifedipine by Country/Region, 2017, 2022 & 2028
2.2 Nifedipine Segment by Type
2.2.1 Nifedipine Controlled Release Tablets
2.2.2 Nifedipine Extended Action Tablets
2.3 Nifedipine Sales by Type
2.3.1 Global Nifedipine Sales Market Share by Type (2017-2022)
2.3.2 Global Nifedipine Revenue and Market Share by Type (2017-2022)
2.3.3 Global Nifedipine Sale Price by Type (2017-2022)
2.4 Nifedipine Segment by Application
2.4.1 Primary Pulmonary Hypertension
2.4.2 Heart Failure
2.4.3 Others
2.5 Nifedipine Sales by Application
2.5.1 Global Nifedipine Sale Market Share by Application (2017-2022)
2.5.2 Global Nifedipine Revenue and Market Share by Application (2017-2022)
2.5.3 Global Nifedipine Sale Price by Application (2017-2022)
3 Global Nifedipine by Company
3.1 Global Nifedipine Breakdown Data by Company
3.1.1 Global Nifedipine Annual Sales by Company (2020-2022)
3.1.2 Global Nifedipine Sales Market Share by Company (2020-2022)
3.2 Global Nifedipine Annual Revenue by Company (2020-2022)
3.2.1 Global Nifedipine Revenue by Company (2020-2022)
3.2.2 Global Nifedipine Revenue Market Share by Company (2020-2022)
3.3 Global Nifedipine Sale Price by Company
3.4 Key Manufacturers Nifedipine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Nifedipine Product Location Distribution
3.4.2 Players Nifedipine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Nifedipine by Geographic Region
4.1 World Historic Nifedipine Market Size by Geographic Region (2017-2022)
4.1.1 Global Nifedipine Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Nifedipine Annual Revenue by Geographic Region
4.2 World Historic Nifedipine Market Size by Country/Region (2017-2022)
4.2.1 Global Nifedipine Annual Sales by Country/Region (2017-2022)
4.2.2 Global Nifedipine Annual Revenue by Country/Region
4.3 Americas Nifedipine Sales Growth
4.4 APAC Nifedipine Sales Growth
4.5 Europe Nifedipine Sales Growth
4.6 Middle East & Africa Nifedipine Sales Growth
5 Americas
5.1 Americas Nifedipine Sales by Country
5.1.1 Americas Nifedipine Sales by Country (2017-2022)
5.1.2 Americas Nifedipine Revenue by Country (2017-2022)
5.2 Americas Nifedipine Sales by Type
5.3 Americas Nifedipine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Nifedipine Sales by Region
6.1.1 APAC Nifedipine Sales by Region (2017-2022)
6.1.2 APAC Nifedipine Revenue by Region (2017-2022)
6.2 APAC Nifedipine Sales by Type
6.3 APAC Nifedipine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Nifedipine by Country
7.1.1 Europe Nifedipine Sales by Country (2017-2022)
7.1.2 Europe Nifedipine Revenue by Country (2017-2022)
7.2 Europe Nifedipine Sales by Type
7.3 Europe Nifedipine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Nifedipine by Country
8.1.1 Middle East & Africa Nifedipine Sales by Country (2017-2022)
8.1.2 Middle East & Africa Nifedipine Revenue by Country (2017-2022)
8.2 Middle East & Africa Nifedipine Sales by Type
8.3 Middle East & Africa Nifedipine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Nifedipine
10.3 Manufacturing Process Analysis of Nifedipine
10.4 Industry Chain Structure of Nifedipine
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Nifedipine Distributors
11.3 Nifedipine Customer
12 World Forecast Review for Nifedipine by Geographic Region
12.1 Global Nifedipine Market Size Forecast by Region
12.1.1 Global Nifedipine Forecast by Region (2023-2028)
12.1.2 Global Nifedipine Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Nifedipine Forecast by Type
12.7 Global Nifedipine Forecast by Application
13 Key Players Analysis
13.1 Bayer
13.1.1 Bayer Company Information
13.1.2 Bayer Nifedipine Product Offered
13.1.3 Bayer Nifedipine Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Bayer Main Business Overview
13.1.5 Bayer Latest Developments
13.2 Actavis
13.2.1 Actavis Company Information
13.2.2 Actavis Nifedipine Product Offered
13.2.3 Actavis Nifedipine Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Actavis Main Business Overview
13.2.5 Actavis Latest Developments
13.3 Teva
13.3.1 Teva Company Information
13.3.2 Teva Nifedipine Product Offered
13.3.3 Teva Nifedipine Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Teva Main Business Overview
13.3.5 Teva Latest Developments
13.4 Pfizer
13.4.1 Pfizer Company Information
13.4.2 Pfizer Nifedipine Product Offered
13.4.3 Pfizer Nifedipine Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Pfizer Main Business Overview
13.4.5 Pfizer Latest Developments
13.5 Shyndec
13.5.1 Shyndec Company Information
13.5.2 Shyndec Nifedipine Product Offered
13.5.3 Shyndec Nifedipine Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Shyndec Main Business Overview
13.5.5 Shyndec Latest Developments
13.6 Honglin
13.6.1 Honglin Company Information
13.6.2 Honglin Nifedipine Product Offered
13.6.3 Honglin Nifedipine Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Honglin Main Business Overview
13.6.5 Honglin Latest Developments
13.7 Huanghai
13.7.1 Huanghai Company Information
13.7.2 Huanghai Nifedipine Product Offered
13.7.3 Huanghai Nifedipine Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Huanghai Main Business Overview
13.7.5 Huanghai Latest Developments
13.8 Yabao
13.8.1 Yabao Company Information
13.8.2 Yabao Nifedipine Product Offered
13.8.3 Yabao Nifedipine Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Yabao Main Business Overview
13.8.5 Yabao Latest Developments
14 Research Findings and Conclusion
Table 1. Nifedipine Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Nifedipine Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Nifedipine Controlled Release Tablets
Table 4. Major Players of Nifedipine Extended Action Tablets
Table 5. Global Nifedipine Sales by Type (2017-2022) & (MT)
Table 6. Global Nifedipine Sales Market Share by Type (2017-2022)
Table 7. Global Nifedipine Revenue by Type (2017-2022) & ($ million)
Table 8. Global Nifedipine Revenue Market Share by Type (2017-2022)
Table 9. Global Nifedipine Sale Price by Type (2017-2022) & (USD/Kg)
Table 10. Global Nifedipine Sales by Application (2017-2022) & (MT)
Table 11. Global Nifedipine Sales Market Share by Application (2017-2022)
Table 12. Global Nifedipine Revenue by Application (2017-2022)
Table 13. Global Nifedipine Revenue Market Share by Application (2017-2022)
Table 14. Global Nifedipine Sale Price by Application (2017-2022) & (USD/Kg)
Table 15. Global Nifedipine Sales by Company (2020-2022) & (MT)
Table 16. Global Nifedipine Sales Market Share by Company (2020-2022)
Table 17. Global Nifedipine Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Nifedipine Revenue Market Share by Company (2020-2022)
Table 19. Global Nifedipine Sale Price by Company (2020-2022) & (USD/Kg)
Table 20. Key Manufacturers Nifedipine Producing Area Distribution and Sales Area
Table 21. Players Nifedipine Products Offered
Table 22. Nifedipine Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Nifedipine Sales by Geographic Region (2017-2022) & (MT)
Table 26. Global Nifedipine Sales Market Share Geographic Region (2017-2022)
Table 27. Global Nifedipine Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Nifedipine Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Nifedipine Sales by Country/Region (2017-2022) & (MT)
Table 30. Global Nifedipine Sales Market Share by Country/Region (2017-2022)
Table 31. Global Nifedipine Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Nifedipine Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Nifedipine Sales by Country (2017-2022) & (MT)
Table 34. Americas Nifedipine Sales Market Share by Country (2017-2022)
Table 35. Americas Nifedipine Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Nifedipine Revenue Market Share by Country (2017-2022)
Table 37. Americas Nifedipine Sales by Type (2017-2022) & (MT)
Table 38. Americas Nifedipine Sales Market Share by Type (2017-2022)
Table 39. Americas Nifedipine Sales by Application (2017-2022) & (MT)
Table 40. Americas Nifedipine Sales Market Share by Application (2017-2022)
Table 41. APAC Nifedipine Sales by Region (2017-2022) & (MT)
Table 42. APAC Nifedipine Sales Market Share by Region (2017-2022)
Table 43. APAC Nifedipine Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Nifedipine Revenue Market Share by Region (2017-2022)
Table 45. APAC Nifedipine Sales by Type (2017-2022) & (MT)
Table 46. APAC Nifedipine Sales Market Share by Type (2017-2022)
Table 47. APAC Nifedipine Sales by Application (2017-2022) & (MT)
Table 48. APAC Nifedipine Sales Market Share by Application (2017-2022)
Table 49. Europe Nifedipine Sales by Country (2017-2022) & (MT)
Table 50. Europe Nifedipine Sales Market Share by Country (2017-2022)
Table 51. Europe Nifedipine Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Nifedipine Revenue Market Share by Country (2017-2022)
Table 53. Europe Nifedipine Sales by Type (2017-2022) & (MT)
Table 54. Europe Nifedipine Sales Market Share by Type (2017-2022)
Table 55. Europe Nifedipine Sales by Application (2017-2022) & (MT)
Table 56. Europe Nifedipine Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Nifedipine Sales by Country (2017-2022) & (MT)
Table 58. Middle East & Africa Nifedipine Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Nifedipine Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Nifedipine Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Nifedipine Sales by Type (2017-2022) & (MT)
Table 62. Middle East & Africa Nifedipine Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Nifedipine Sales by Application (2017-2022) & (MT)
Table 64. Middle East & Africa Nifedipine Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Nifedipine
Table 66. Key Market Challenges & Risks of Nifedipine
Table 67. Key Industry Trends of Nifedipine
Table 68. Nifedipine Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Nifedipine Distributors List
Table 71. Nifedipine Customer List
Table 72. Global Nifedipine Sales Forecast by Region (2023-2028) & (MT)
Table 73. Global Nifedipine Sales Market Forecast by Region
Table 74. Global Nifedipine Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Nifedipine Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Nifedipine Sales Forecast by Country (2023-2028) & (MT)
Table 77. Americas Nifedipine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Nifedipine Sales Forecast by Region (2023-2028) & (MT)
Table 79. APAC Nifedipine Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Nifedipine Sales Forecast by Country (2023-2028) & (MT)
Table 81. Europe Nifedipine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Nifedipine Sales Forecast by Country (2023-2028) & (MT)
Table 83. Middle East & Africa Nifedipine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Nifedipine Sales Forecast by Type (2023-2028) & (MT)
Table 85. Global Nifedipine Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Nifedipine Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Nifedipine Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Nifedipine Sales Forecast by Application (2023-2028) & (MT)
Table 89. Global Nifedipine Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Nifedipine Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Nifedipine Revenue Market Share Forecast by Application (2023-2028)
Table 92. Bayer Basic Information, Nifedipine Manufacturing Base, Sales Area and Its Competitors
Table 93. Bayer Nifedipine Product Offered
Table 94. Bayer Nifedipine Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 95. Bayer Main Business
Table 96. Bayer Latest Developments
Table 97. Actavis Basic Information, Nifedipine Manufacturing Base, Sales Area and Its Competitors
Table 98. Actavis Nifedipine Product Offered
Table 99. Actavis Nifedipine Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 100. Actavis Main Business
Table 101. Actavis Latest Developments
Table 102. Teva Basic Information, Nifedipine Manufacturing Base, Sales Area and Its Competitors
Table 103. Teva Nifedipine Product Offered
Table 104. Teva Nifedipine Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 105. Teva Main Business
Table 106. Teva Latest Developments
Table 107. Pfizer Basic Information, Nifedipine Manufacturing Base, Sales Area and Its Competitors
Table 108. Pfizer Nifedipine Product Offered
Table 109. Pfizer Nifedipine Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 110. Pfizer Main Business
Table 111. Pfizer Latest Developments
Table 112. Shyndec Basic Information, Nifedipine Manufacturing Base, Sales Area and Its Competitors
Table 113. Shyndec Nifedipine Product Offered
Table 114. Shyndec Nifedipine Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 115. Shyndec Main Business
Table 116. Shyndec Latest Developments
Table 117. Honglin Basic Information, Nifedipine Manufacturing Base, Sales Area and Its Competitors
Table 118. Honglin Nifedipine Product Offered
Table 119. Honglin Nifedipine Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 120. Honglin Main Business
Table 121. Honglin Latest Developments
Table 122. Huanghai Basic Information, Nifedipine Manufacturing Base, Sales Area and Its Competitors
Table 123. Huanghai Nifedipine Product Offered
Table 124. Huanghai Nifedipine Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 125. Huanghai Main Business
Table 126. Huanghai Latest Developments
Table 127. Yabao Basic Information, Nifedipine Manufacturing Base, Sales Area and Its Competitors
Table 128. Yabao Nifedipine Product Offered
Table 129. Yabao Nifedipine Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 130. Yabao Main Business
Table 131. Yabao Latest Developments
List of Figures
Figure 1. Picture of Nifedipine
Figure 2. Nifedipine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Nifedipine Sales Growth Rate 2017-2028 (MT)
Figure 7. Global Nifedipine Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Nifedipine Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Nifedipine Controlled Release Tablets
Figure 10. Product Picture of Nifedipine Extended Action Tablets
Figure 11. Global Nifedipine Sales Market Share by Type in 2021
Figure 12. Global Nifedipine Revenue Market Share by Type (2017-2022)
Figure 13. Nifedipine Consumed in Primary Pulmonary Hypertension
Figure 14. Global Nifedipine Market: Primary Pulmonary Hypertension (2017-2022) & (MT)
Figure 15. Nifedipine Consumed in Heart Failure
Figure 16. Global Nifedipine Market: Heart Failure (2017-2022) & (MT)
Figure 17. Nifedipine Consumed in Others
Figure 18. Global Nifedipine Market: Others (2017-2022) & (MT)
Figure 19. Global Nifedipine Sales Market Share by Application (2017-2022)
Figure 20. Global Nifedipine Revenue Market Share by Application in 2021
Figure 21. Nifedipine Revenue Market by Company in 2021 ($ Million)
Figure 22. Global Nifedipine Revenue Market Share by Company in 2021
Figure 23. Global Nifedipine Sales Market Share by Geographic Region (2017-2022)
Figure 24. Global Nifedipine Revenue Market Share by Geographic Region in 2021
Figure 25. Global Nifedipine Sales Market Share by Region (2017-2022)
Figure 26. Global Nifedipine Revenue Market Share by Country/Region in 2021
Figure 27. Americas Nifedipine Sales 2017-2022 (MT)
Figure 28. Americas Nifedipine Revenue 2017-2022 ($ Millions)
Figure 29. APAC Nifedipine Sales 2017-2022 (MT)
Figure 30. APAC Nifedipine Revenue 2017-2022 ($ Millions)
Figure 31. Europe Nifedipine Sales 2017-2022 (MT)
Figure 32. Europe Nifedipine Revenue 2017-2022 ($ Millions)
Figure 33. Middle East & Africa Nifedipine Sales 2017-2022 (MT)
Figure 34. Middle East & Africa Nifedipine Revenue 2017-2022 ($ Millions)
Figure 35. Americas Nifedipine Sales Market Share by Country in 2021
Figure 36. Americas Nifedipine Revenue Market Share by Country in 2021
Figure 37. United States Nifedipine Revenue Growth 2017-2022 ($ Millions)
Figure 38. Canada Nifedipine Revenue Growth 2017-2022 ($ Millions)
Figure 39. Mexico Nifedipine Revenue Growth 2017-2022 ($ Millions)
Figure 40. Brazil Nifedipine Revenue Growth 2017-2022 ($ Millions)
Figure 41. APAC Nifedipine Sales Market Share by Region in 2021
Figure 42. APAC Nifedipine Revenue Market Share by Regions in 2021
Figure 43. China Nifedipine Revenue Growth 2017-2022 ($ Millions)
Figure 44. Japan Nifedipine Revenue Growth 2017-2022 ($ Millions)
Figure 45. South Korea Nifedipine Revenue Growth 2017-2022 ($ Millions)
Figure 46. Southeast Asia Nifedipine Revenue Growth 2017-2022 ($ Millions)
Figure 47. India Nifedipine Revenue Growth 2017-2022 ($ Millions)
Figure 48. Australia Nifedipine Revenue Growth 2017-2022 ($ Millions)
Figure 49. Europe Nifedipine Sales Market Share by Country in 2021
Figure 50. Europe Nifedipine Revenue Market Share by Country in 2021
Figure 51. Germany Nifedipine Revenue Growth 2017-2022 ($ Millions)
Figure 52. France Nifedipine Revenue Growth 2017-2022 ($ Millions)
Figure 53. UK Nifedipine Revenue Growth 2017-2022 ($ Millions)
Figure 54. Italy Nifedipine Revenue Growth 2017-2022 ($ Millions)
Figure 55. Russia Nifedipine Revenue Growth 2017-2022 ($ Millions)
Figure 56. Middle East & Africa Nifedipine Sales Market Share by Country in 2021
Figure 57. Middle East & Africa Nifedipine Revenue Market Share by Country in 2021
Figure 58. Egypt Nifedipine Revenue Growth 2017-2022 ($ Millions)
Figure 59. South Africa Nifedipine Revenue Growth 2017-2022 ($ Millions)
Figure 60. Israel Nifedipine Revenue Growth 2017-2022 ($ Millions)
Figure 61. Turkey Nifedipine Revenue Growth 2017-2022 ($ Millions)
Figure 62. GCC Country Nifedipine Revenue Growth 2017-2022 ($ Millions)
Figure 63. Manufacturing Cost Structure Analysis of Nifedipine in 2021
Figure 64. Manufacturing Process Analysis of Nifedipine
Figure 65. Industry Chain Structure of Nifedipine
Figure 66. Channels of Distribution
Figure 67. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...